WASHINGTON (AP) — Amgen Inc. has won approval for the second medicine in a new class of biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used f…
Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Thu, 08/27/2015 - 2:18pm